SCHEMBL26591995

SCHEMBL26591995

N#Cc1ccc(-c2cccc(-c3nc(-c4ccc5cc(-c6ccc7ccccc7c6)ccc5c4)nc(-c4cc(-c5ccccc5)ccc4-c4ccccc4)n3)c2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 2/20 0.43
CYP11B2 P19099 2/20 0.43
CYP17A1 P05093 1/20 0.43
KDM1A O60341 1/20 0.42
ABCG2 Q9UNQ0 7/20 0.42
ABCB1 P08183 5/20 0.42
ADORA2A P29274 1/20 0.41
ADORA1 P30542 1/20 0.41
GABRA1 P14867 1/20 0.40
GABRG2 P18507 1/20 0.40
GABRB3 P28472 1/20 0.40
GABRA5 P31644 1/20 0.40
GABRA3 P34903 1/20 0.40
KAT6A Q92794 1/20 0.39
ABCC1 P33527 2/20 0.38
MYC P01106 1/20 0.38
HSD17B1 P14061 1/20 0.38
HSD17B2 P37059 1/20 0.38
MEN1 O00255 1/20 0.38
NPC1 O15118 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26591992 0.99 ABCG2 (0.44) CYP11B1CYP11B2CYP17A1KDM1AABCG2
SCHEMBL26591989 0.99 ABCG2 (0.44) CYP11B1CYP11B2CYP17A1KDM1AABCG2
SCHEMBL26591993 0.97 CYP17A1 (0.45) CYP11B1CYP11B2CYP17A1KDM1AABCG2
SCHEMBL26591984 0.96 ABCG2 (0.44) CYP11B1CYP11B2CYP17A1KDM1AABCG2
SCHEMBL26591985 0.96 ABCG2 (0.44) CYP11B1CYP11B2CYP17A1KDM1AABCG2
SCHEMBL26592010 0.94 ABCG2 (0.46) CYP11B1CYP11B2CYP17A1KDM1AABCG2
SCHEMBL26592011 0.93 ABCG2 (0.48) CYP11B1CYP11B2CYP17A1KDM1AABCG2
SCHEMBL26591975 0.92 ABCG2 (0.47) CYP11B1CYP11B2CYP17A1KDM1AABCG2
SCHEMBL31643063 0.92 ABCG2 (0.49) ABCG2ABCB1GABRA1GABRG2GABRB3
SCHEMBL31642854 0.92 ABCG2 (0.49) ABCG2ABCB1GABRA1GABRG2GABRB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230337532-A1 TRIAZINE COMPOUND, MATERIAL FOR ORGANIC LIGHT EMITTING DIODE, ELECTRON TRANSPORT MATERIAL FOR ORGANIC LIGHT EMITTING DIODE, AND ORGANIC LIGHT EMITTING DIODE TOSOH CORPORATION (JP) 2023-10-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230337532-A1 TRIAZINE COMPOUND, MATERIAL FOR ORGANIC LIGHT EMITTING DIODE, ELECTRON TRANSPORT MATERIAL FOR ORGANIC LIGHT EMITTING DIODE, AND ORGANIC LIGHT EMITTING DIODE ARNT, TPH1, AHR CYP11B1 321/4885CYP11B2 277/4885CYP17A1 1304/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.